Sleep Disorders and Menopause

키워드

참고문헌 (55)

1. Miller EH., "Women and insomnia", Clin Cornerstone, 6(Suppl 1B), pp.S8~S18 (2004)
2. Freedman RR, "Postmenopausal physiological changes", Curr Top Behav Neurosci, 21, pp.245~256 (2014)
3. Twiss JJ, "Perimenopausal symptoms, quality of life, and health behaviors in users and nonusers of hormone therapy", J Am Acad Nurse Pract, 19, pp.602~613 (2007)
4. Weber MT, "Cognition in perimenopause : the effect of transition stage", Menopause, 20, pp.511~517 (2013)
5. Schmidt PJ., "Mood, depression, and reproductive hormones in the menopausal transition", Am J Med, 118(Suppl 12B), pp.54~58 (2005)
6. 상재홍, "Flibanserin for Treating Hypoactive Sexual Desire Disorder", 대한폐경학회지, 22(1), pp.9~13 (2016), 대한폐경학회
7. Kravitz HM, "Sleep during the perimenopause : a SWAN story", Obstet Gynecol Clin North Am, 38, pp.567~586 (2011)
8. Chokroverty S, "Overview of sleep & sleep disorders", Indian J Med Res, 131, pp.126~140 (2010)
9. Guidozzi F, "Sleep and sleep disorders in menopausal women", Climacteric, 16, pp.214~219 (2013)
10. Al-Safi ZA, "Menopausal hormone therapy and menopausal symptoms", Fertil Steril, 101, pp.905~915 (2014)
11. Fatemeh Abdi, "Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action", 대한폐경학회지, 22(2), pp.62~64 (2016), 대한폐경학회
12. Lampio L, "Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms", Menopause, 21, pp.1217~1224 (2014)
13. Polo-Kantola P, "Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women", Fertil Steril, 71, pp.873~880 (1999)
14. Young T, "Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study", Sleep, 26, pp.667~672 (2003)
15. Manber R, "Sex, steroids, and sleep: a review", Sleep, 22, pp.540~555 (1999)
16. Empson JA, "Effects of sex steroids on sleep", Ann Med, 31, pp.141~145 (1999)
17. Polo-Kantola P, "Dealing with menopausal sleep disturbances", Sleep Med Clin, 3, pp.121~131 (2008)
18. Scharf MB, "Effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women : a pilot study", Clin Ther, 19, pp.304~311 (1997)
19. Freedman RR, "Core body temperature during menopausal hot flushes", Fertil Steril, 65, pp.1141~1144 (1996)
20. Eichling PS, "Menopause related sleep disorders", J Clin Sleep Med, 1, pp.291~300 (2005)
21. Grigoriadis S, "Role of estrogen in the treatment of depression", Am J Ther, 9, pp.503~509 (2002)
22. Welton AJ, "Health related quality of life after combined hormone replacement therapy: randomised controlled trial", BMJ, 337, pp.a1190~ (2008)
23. Barnabei VM, "Menopausal symptoms in older women and the effects of treatment with hormone therapy", Obstet Gynecol, 100, pp.1209~1218 (2002)
24. Okatani Y, "Changes in nocturnal melatonin secretion in perimenopausal women : correlation with endogenous estrogen concentrations", J Pineal Res, 28, pp.111~118 (2000)
25. Lemoine P, "Prolonged-release formulation of melatonin(Circadin)for the treatment of insomnia", Expert Opin Pharmacother, 13, pp.895~905 (2012)
26. Lemoine P, "Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects", J Sleep Res, 16, pp.372~380 (2007)
27. Kato K, "Neurochemical properties of ramelteon (TAK-375), a selective MT1", MT2 receptor agonist, 2005, pp.48, 301~310
28. Miyamoto M., "Pharmacology of ramelteon, a selective MT1", MT2receptor agonist: a novel therapeutic drug for sleep disorders, 2009, pp.15, 32~51
29. Pandi-Perumal SR, "Ramelteon : a review of its therapeutic potential in sleep disorders", Adv Ther, 26, pp.613~626 (2009)
30. Hardeland R, "Melatonergic drugs in clinical practice", Arzneimittelforschung, 58, pp.1~10 (2008)
31. Millan MJ, "The novel melatonin agonist agomelatine (S20098)is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways", J Pharmacol Exp Ther, 306, pp.954~964 (2003)
32. Dorsey CM, "Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study", Clin Ther, 26, pp.1578~1586 (2004)
33. Ohayon MM, "Epidemiology of restless legs syndrome : a synthesis of the literature", Sleep Med Rev, 16, pp.283~295 (2012)
34. Soares CN, "Eszopiclone in patients with insomnia during perimenopause and early postmenopause : a randomized controlled trial", Obstet Gynecol, 108, pp.1402~1410 (2006)
35. Srinivasan V, "Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.913~923 (2011)
36. Zlotos DP, "MT1and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential", J Med Chem, 57, pp.3161~3185 (2014)
37. Kennedy SH, "Placebo-controlled trial of agomelatine in the treatment of major depressive disorder", Eur Neuropsychopharmacol, 16, pp.93~100 (2006)
38. Innes KE, "Prevalence of restless legs syndrome in North American and Western European populations : a systematic review", Sleep Med, 12, pp.623~634 (2011)
39. Srinivasan V, "Role of melatonin in mood disorders and the antidepressant effects of agomelatine", Expert Opin Investig Drugs, 21, pp.1503~1522 (2012)
40. Manconi M, "When gender matters: restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group", Sleep Med Rev, 16, pp.297~307 (2012)
41. Parry BL, "Sleep, rhythms and women's mood. Part II. Menopause", Sleep Med Rev, 10, pp.197~208 (2006)
42. Terauchi M, "Associations between anxiety, depression and insomnia in peri- and post-menopausal women", Maturitas, 72, pp.61~65 (2012)
43. Dancey DR, "Impact of menopause on the prevalence and severity of sleep apnea", Chest, 120, pp.151~155 (2001)
44. Resta O, "Prevalence of obstructive sleep apnoea in a sample of obese women : effect of menopause", Diabetes Nutr Metab, 17, pp.296~303 (2004)
45. Donato GB, "Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio", Menopause, 13, pp.280~285 (2006)
46. Resta O, "Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity", Eur J Clin Invest, 33, pp.1084~1089 (2003)
47. Vorona RD, "Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index", Arch Intern Med, 165, pp.25~30 (2005)
48. Bass J, "Sleepless in America: a pathway to obesity and the metabolic syndrome?", Arch Intern Med, 165, pp.15~16 (2005)
49. Phillips BA, "Sleep disorders and medical conditions in women. Proceedings of the Women & Sleep Workshop, National Sleep Foundation, Washington, DC, March 5-6, 2007", J Womens Health(Larchmt), 17, pp.1191~1199 (2008)
50. Manber R, "The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women : a pilot study", Sleep, 26, pp.163~168 (2003)
51. Shahar E, "Hormone replacement therapy and sleep-disordered breathing", Am J Respir Crit Care Med, 167, pp.1186~1192 (2003)
52. Nowakowski S, "Sleep and menopause", Curr Neurol Neurosci Rep, 9, pp.165~172 (2009)
53. Phillips B., "Movement disorders: a sleep specialist's perspective", Neurology, 62, pp.S9~S16 (2004)
54. Viola-Saltzman M, "High prevalence of restless legs syndrome among patients with fibromyalgia : a controlled cross-sectional study", J Clin Sleep Med, 6, pp.423~427 (2010)
55. Littner MR, "Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder", Sleep, 27, pp.557~559 (2004)

관련 논문AI추천